Metagenomi has raised $65 million to apply its suite of CRISPR-based systems to the treatment of genetic diseases. Leaps by Bayer co-led the series A round, continuing the German conglomerate’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results